Skip to main content
The Journal of Nutrition logoLink to The Journal of Nutrition
. 2009 Dec;139(12):2389–2392. doi: 10.3945/jn.109.111856

Repression of Transposable Elements by Histone Biotinylation1,2

Janos Zempleni 1,*, Yap Ching Chew 1, Baolong Bao 1, Valerie Pestinger 1, Subhashinee S K Wijeratne 1
PMCID: PMC2777482  PMID: 19812216

Abstract

Transposable elements constitute >40% of the human genome; transposition of these elements increases genome instability and cancer risk. Epigenetic mechanisms are important for transcriptional repression of retrotransposons, thereby preventing transposition events. Binding of biotin to histones, mediated by holocarboxylase synthetase (HCS), is a novel histone mark that plays a role in gene regulation. Here, we review recent findings that biotinylation of lysine-12 in histone H4 (H4K12bio) is an epigenetic mechanism to repress long terminal repeat (LTR) retrotransposons in human and mouse cell lines, primary cells from human adults, and in Drosophila melanogaster. Further, evidence is summarized that supports a causal relationship between the repression of LTR in H4K12bio-depleted cells and increased production of viral particles, increased frequency of retrotransposition events, and increased frequency of chromosomal abnormalities in mammals and Drosophila. Although HCS interacts physically with histones H3 and H4, the mechanism responsible for targeting HCS to retrotransposons to mediate histone biotinylation is uncertain. We hypothesize that HCS binds specifically to genomic regions rich in methylated cytosines and catalyzes increased biotinylation of histone H4 at lysine-12. Further, we hypothesize that this biotinylation promotes the subsequent dimethylation of lysine-9 in histone H3, resulting in an overall synergistic effect of 3 diet-dependent covalent modifications of histones in the repression of LTR.

Transposable elements

Type I transposable elements constitute ∼42% of the human genome; they predominantly fall into 2 categories, the long terminal repeat (LTR)4-containing retrotransposons and the non-LTR long interspersed nucleotide elements (13). This study focuses on LTR. Mammalian genomes contain 2 types of LTR elements, intact retrotransposon LTR and solitary LTR. In intact retrotransposons, the viral genes gag, pol, and env are flanked by 2 repeat regions: 5′-LTR and 3′-LTR. The expression of retroviral genes is regulated by promoters in the 5′-LTR (4). Transcription of intact retrotransposons by a reverse transcriptase and subsequent translocation impair genomic stability and are associated with various disease states such as cancer and autoimmunity (1,5). In solitary LTR, the retroviral genes have been deleted by recombination between the LTR (1,4,6,7). Although solitary LTR cannot produce viral proteins, they may have promoter activity and can cause abnormal patterns of host gene expression (6,7). Most retrotransposons are inactive, but 54 promoter-active retrotransposons have been identified in human testes (4). Repression of intact retrotransposons and solitary LTR is important to prevent abnormal gene activity and to decrease the incidence of retrotranspositions.

Epigenetic repression of retrotransposons

Histones are posttranslationally modified by various epigenetic marks (Fig. 1) (815). In addition, methylation of cytosine residues in DNA contributes to the arsenal of known chromatin modifications (16). K9-dimethylation of histone H3 (H3K9me2) and methylation of cytosine residues in DNA are known to repress transposable elements (2,17,18). Evidence suggests that chromatin modifications other than methylation marks are also critical for silencing of retroviral elements and for preserving chromosomal stability and human health (19). One of these modifications appears to be biotinylation of histones. The covalent binding of the vitamin biotin to histones is mediated by holocarboxylase synthetase (HCS) (20,21). The following biotinylation sites have been identified: K9, K13, K125, K127, and K129 in histone H2A (13); K4, K9, K18, and perhaps K23 in histone H3 (11); and K8 and K12 in histone H4 (10). Preliminary evidence suggests that K5 and K16 in histone H4 are also targets for biotinylation (10,12). Importantly, K12-biotinylation of histone H4 (H4K12bio) is a mark for repeat regions and heterochromatin, plays a role in gene repression, and colocalizes with the repression mark H3K9me2 (22).

FIGURE 1 .

FIGURE 1 

Modification marks in histones H2A, H3, and H4 (815). Biotinylation sites in histones H1 and H2B have not yet been investigated, and thus, H1 and H2B are not depicted. Abbreviations: Ac, acetate; B, biotin; M, methyl; P, phosphate; U, ubiquitin. Marks labeled with “?” are based on preliminary observations and await confirmation (10,12).

Chromatin immunoprecipitation assays provided evidence that H4K12bio is greatly enriched at loci coding for both intact and solitary LTR in a human lymphoid cell line. Similar observations were made in human and mouse cell lines that originated in other tissues (23). Importantly, the enrichment of H4K12bio depends on the concentration of biotin in cell culture media at nutritionally relevant levels, consistent with a diet (biotin)-dependent epigenetic mark. Similar observations were made in a supplementation study in apparently healthy human adults, where supplementation with a typical over-the-counter biotin supplement increased the enrichment of H4K12bio at LTR in primary peripheral blood mononuclear cells (23).

These observations relate to a mechanism that likely has substantial biological importance as follows. First, decreased enrichment of H4K12bio at LTR in biotin-deficient or HCS knockdown cells is associated with increased LTR transcript abundance (23). Transcription of LTR is the first and critical step in retrotransposition events (2). Second, murine Mm5MT mammary carcinoma cells are known to produce particles of mouse mammary tumor virus (24). Decreased enrichment of H4K12bio in biotin-deficient Mm5MT cells is associated with increased secretion of viral particles, encoded by the viral genes gag, pol, and env, into culture media (23). Third, studies in Drosophila melanogaster are consistent with the hypothesis that decreased histone biotinylation increases the frequency of retrotransposition events. In Drosophila, ovoD1 females are sterile because of a point mutation that resulted in the dominant arrest of oogenesis (25). HCS knockdown, ovoD1 females revert spontaneously to fertility as a result of the insertion of the endogenous retrovirus gypsy or the retrotransposon copia (26). If histone biotinylation in ovoD1 females is decreased by knocking down HCS, the frequency of retrotransposition events is ∼4 times that in HCS wild-type ovoD1 females (23). Fourth, some of the known histone biotinylation marks are not enriched at LTR, suggesting specificity for H4K12bio in the repression of retrotransposons (23). Fifth, chromosomal abnormalities are detectable in biotin-deficient human lymphoid cells but not in biotin-normal and biotin-supplemented cells (23).

Repression of LTR (and other gene loci) depends on cross-talk between H4K12bio and methylation marks. If cytosine methylation is decreased by treating cells with 5′-azacytidine, the enrichment of H4K12bio at LTR is reduced by ∼50% (23). In contrast, if the abundance of H4K12bio is decreased in biotin-deficient cells, cytosine methylation remains unaltered. However, if H4K12bio is decreased in biotin-deficient cells of HCS knockdown cells, the local enrichment of H3K9me2 at the same locus decreases substantially (22,23,27). The latter is consistent with preliminary observations that HCS physically interacts with a histone H3 K9-methyltransferase (28). Based on these observations we propose a model in which methylcytosine-binding proteins such as MeCP2 direct HCS (and other enzymes) to loci rich in methylated DNA, triggering local biotinylation of histone H4 (Fig. 2). Histone H3 K9-methyltransferases are also part of this multiprotein complex, leading to enrichment of H3K9me2. According to this model, 3 nutrient-dependent repression marks (cytosine methylation, H4K12bio, H3K9me2) synergize in the repression of LTR.

FIGURE 2 .

FIGURE 2 

Epigenetic synergies between biotin- and folate-dependent chromatin marks in the repression of LTR.

Holocarboxylase synthetase

Attachment of biotin to histones is mediated by holocarboxylase synthetase (HCS, EC 6.3.4.10) (20,21,27). The following 4 domains have been identified and characterized in human HCS: N-terminal domain, central domain, linker domain, and C-terminal domain (29). Both N- and C-termini of HCS participate in substrate recognition (29). The central domain in HCS contains binding sites for both ATP and biotin (3032). Mutations and knockdown of HCS decrease the abundance of biotinylated histones (20,21,27), leading to abnormal patterns of gene expression (21,27) and phenotypes such as altered life span and stress resistance (21,33).

HCS does not interact directly with histone H2A; biotinylation of histone H2A is mediated by diffusion of the HCS-generated intermediate biotinyl-5′-AMP to its target site (34). In contrast, HCS appears to interact physically with histones H3 and H4 to mediate biotinylation (B. Baolong, V. Pestinger, Y. I. Hassan, and J. Zempleni, unpublished data). These observations suggest that interactions between HCS and the H3/H3/H4/H4 tetramer (but not H2A/H2B dimers) in nucleosomes might contribute to the binding of HCS to chromatin. This theory is not mutually exclusive with the methyl cytosine-directed targeting of HCS to distinct chromosomal loci (Fig. 2).

Conclusions

This article summarizes recent evidence concerning the repression of transposable elements by histone biotinylation and offers a novel mechanistic hypothesis concerning the diet-dependent epigenetic repression of transposable elements. Biotin-dependent repression is reinforced by newly discovered epigenetic synergies between H4K12bio and folate-dependent marks such as H3K9me2 and methylation of cytosine residues. The phenomena described here are potentially important for human health and provide a mechanistic link between biotin deficiency and chromosomal abnormalities in humans.

Other articles in the supplement include references (3538).

Acknowledgments

J.Z., Y.C.C., and B.B. designed research; Y.C.C., B.B., V.P., and S.S.K.W. conducted research; J.Z. and Y.C.C. analyzed data; J.Z. wrote the paper and had primary responsibility for final content. All authors read and approved the final manuscript.

1

Presented as part of the symposium entitled “Nutrients and Epigenetic Regulation of Gene Expression” at the Experimental Biology 2009 meeting, April 20, 2009, in New Orleans, LA. This symposium was sponsored the American Society for Nutrition (ASN) and had no outside support declared. The Guest Editor for this symposium publication was Kevin Schalinske. Guest Editor disclosure: no relationships to disclose.

2

A contribution of the University of Nebraska Agricultural Research Division, supported in part by funds provided through the Hatch Act. Additional support was provided by NIH grants DK063945, DK077816, DK082476, and ES015206, USDA grant 2006-35200-17138, and by NSF grant EPS-0701892.

3

Author disclosures: J. Zempleni, Y. C. Chew, B. Bao, V. Pestinger, and S. S. K. Wijeratne, no conflicts of interest.

4

Abbreviations used: H3K9me2, K9-dimethylated histone H3; H4K12bio, K12-biotinylated histone H4; HCS, holocarboxylase synthetase; LTR, long terminal repeats.

References

  • 1.Bannert N, Kurth R. Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci USA. 2004;101:14572–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Slotkin RK, Martienssen R. Transposable elements and the epigenetic regulation of the genome. Nat Rev Genet. 2007;8:272–85. [DOI] [PubMed] [Google Scholar]
  • 3.Mills RE, Bennett EA, Iskow RC, Devine SE. Which transposable elements are active in the human genome? Trends Genet. 2007;23:183–91. [DOI] [PubMed] [Google Scholar]
  • 4.Buzdin A, Kovalskaya-Alexandrova E, Gogvadze E, Sverdlov E. GREM, a technique for genome-wide isolation and quantitative analysis of promoter active repeats. Nucleic Acids Res. 2006;34:e67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lewin B. Genes VIII. Upper Saddle River, NJ: Pearson Prentice Hall; 2004.
  • 6.Vinogradova TV, Leppik LP, Nikolaev LG, Akopov SB, Kleiman AM, Senyuta NB, Sverdlov ED. Solitary human endogenous retroviruses-K LTRs retain transcriptional activity in vivo, the mode of which is different in different cell types. Virology. 2001;290:83–90. [DOI] [PubMed] [Google Scholar]
  • 7.Kovalskaya E, Buzdin A, Gogvadze E, Vinogradova T, Sverdlov E. Functional human endogenous retroviral LTR transcription start sites are located between the R and U5 regions. Virology. 2006;346:373–8. [DOI] [PubMed] [Google Scholar]
  • 8.Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293:1074–80. [DOI] [PubMed] [Google Scholar]
  • 9.Fischle W, Wang Y, Allis CD. Histone and chromatin cross-talk. Curr Opin Cell Biol. 2003;15:172–83. [DOI] [PubMed] [Google Scholar]
  • 10.Camporeale G, Shubert EE, Sarath G, Cerny R, Zempleni J. K8 and K12 are biotinylated in human histone H4. Eur J Biochem. 2004;271:2257–63. [DOI] [PubMed] [Google Scholar]
  • 11.Kobza K, Camporeale G, Rueckert B, Kueh A, Griffin JB, Sarath G, Zempleni J. K4, K9, and K18 in human histone H3 are targets for biotinylation by biotinidase. FEBS J. 2005;272:4249–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chew YC, Raza AS, Sarath G, Zempleni J. Biotinylation of K8 and K12 co-occurs with acetylation and mono-methylation in human histone H4. FASEB J. 2006;20:A610. [Google Scholar]
  • 13.Chew YC, Camporeale G, Kothapalli N, Sarath G, Zempleni J. Lysine residues in N- and C-terminal regions of human histone H2A are targets for biotinylation by biotinidase. J Nutr Biochem. 2006;17:225–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kobza K, Sarath G, Zempleni J. Prokaryotic BirA ligase biotinylates K4, K9, K18 and K23 in histone H3. BMB Rep. 2008;41:310–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kouzarides T, Berger SL. Chromatin modifications and their mechanism of action. In: Allis CD, Jenuwein T, Reinberg D, editors. Epigenetics. Cold Spring Harbor, NY: Cold Spring Harbor Press; 2007. p. 191–209.
  • 16.Li E, Bird A. DNA methylation in mammals. In: Allis CD, Jenuwein T, Reinberg D, editors. Epigenetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2007. p. 341–56.
  • 17.Jaenisch R, Schnieke A, Harbers K. Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues. Proc Natl Acad Sci USA. 1985;82:1451–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Martens JH, O'Sullivan RJ, Braunschweig U, Opravil S, Radolf M, Steinlein P, Jenuwein T. The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 2005;24:800–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Yao S, Sukonnik T, Kean T, Bharadwaj RR, Pasceri P, Ellis J. Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. Mol Ther. 2004;10:27–36. [DOI] [PubMed] [Google Scholar]
  • 20.Narang MA, Dumas R, Ayer LM, Gravel RA. Reduced histone biotinylation in multiple carboxylase deficiency patients: a nuclear role for holocarboxylase synthetase. Hum Mol Genet. 2004;13:15–23. [DOI] [PubMed] [Google Scholar]
  • 21.Camporeale G, Giordano E, Rendina R, Zempleni J, Eissenberg JC. Drosophila holocarboxylase synthetase is a chromosomal protein required for normal histone biotinylation, gene transcription patterns, lifespan and heat tolerance. J Nutr. 2006;136:2735–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Camporeale G, Oommen AM, Griffin JB, Sarath G, Zempleni J. K12-biotinylated histone H4 marks heterochromatin in human lymphoblastoma cells. J Nutr Biochem. 2007;18:760–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Chew YC, West JT, Kratzer SJ, Ilvarsonn AM, Eissenberg JC, Dave BJ, Klinkebiel D, Christman JK, Zempleni J. Biotinylation of histones represses transposable elements in human and mouse cells and cell lines, and in Drosophila melanogaster. J Nutr. 2008;138:2316–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Scheidereit C, Geisse S, Westphal HM, Beato M. The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumour virus. Nature. 1983;304:749–52. [DOI] [PubMed] [Google Scholar]
  • 25.Mevel-Ninio M, Fouilloux E, Guenal I, Vincent A. The three dominant female-sterile mutations of the Drosophila ovo gene are point mutations that create new translation-initiator AUG codons. Development. 1996;122:4131–8. [DOI] [PubMed] [Google Scholar]
  • 26.Mevel-Ninio M, Mariol MC, Gans M. Mobilization of the gypsy and copia retrotransposons in Drosophila melanogaster induces reversion of the ovo dominant female-sterile mutations: molecular analysis of revertant alleles. EMBO J. 1989;8:1549–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gralla M, Camporeale G, Zempleni J. Holocarboxylase synthetase regulates expression of biotin transporters by chromatin remodeling events at the SMVT locus. J Nutr Biochem. 2008;19:400–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zempleni J, Chew YC, Hassan YI, Wijeratne SS. Epigenetic regulation of chromatin structure and gene function by biotin: are biotin requirements being met? Nutr Rev. 2008;66: Suppl 1:S46–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hassan YI, Moriyama H, Olsen LJ, Bi X, Zempleni J. N- and C-terminal domains in human holocarboxylase synthetase participate in substrate recognition. Mol Genet Metab. 2009;96:183–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Leon-Del-Rio A, Gravel RA. Sequence requirements for the biotinylation of carboxyl-terminal fragments of human propionyl-CoA carboxylase alpha subunit expressed in Escherichia coli. J Biol Chem. 1994;269:22964–8. [PubMed] [Google Scholar]
  • 31.Chapman-Smith A, Cronan JEJ. Molecular biology of biotin attachment to proteins. J Nutr. 1999;129:477S–84S. [DOI] [PubMed] [Google Scholar]
  • 32.Campeau E, Gravel RA. Expression in Escherichia coli of N- and C-terminally deleted human holocarboxylase synthetase. Influence of the N-terminus on biotinylation and identification of a minimum functional protein. J Biol Chem. 2001;276:12310–6. [DOI] [PubMed] [Google Scholar]
  • 33.Camporeale G, Zempleni J, Eissenberg JC. Susceptibility to heat stress and aberrant gene expression patterns in holocarboxylase synthetase-deficient Drosophila melanogaster are caused by decreased biotinylation of histones, not of carboxylases. J Nutr. 2007;137:885–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Healy S, Heightman TD, Hohmann L, Schriemer D, Gravel RA. Nonenzymatic biotinylation of histone H2A. Protein Sci. 2009;18:314–28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ho E, Zempleni J. Overview to symposium “Nutrients and Epigenetic Regulation of Gene Expression.”. J Nutr. 2009;139:2387–8. [DOI] [PubMed] [Google Scholar]
  • 36.Ho E, Clarke JD, Dashwood RH. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J Nutr. 2009;139:2393–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kirkland JB. Niacin status impacts chromatin structure. J Nutr. 2009;139:2397–401. [DOI] [PubMed] [Google Scholar]
  • 38.Stover PJ. One-carbon metabolism–genome interactions in folate-associated pathologies. J Nutr. 2009;139:2402–5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Nutrition are provided here courtesy of American Society for Nutrition

RESOURCES